Type II diabetes treatment market value in Asia-Pacific to hit $10.5 billion by 2020: GBI Research Read more
Jubilant Life Sciences, Lupin and Aurobindo Pharma receives US FDA approval for Valsartan tabs Read more
Jubilant Life Sciences receives US FDA nod for Mycophenolate and MofetilRizatriptan tablets Read more